U.S. Charges FDA Chemist in $3 Million Inside-Trading Scheme

A U.S. Food and Drug Administration chemist and his son were arrested by federal authorities and accused of reaping at least $3 million from trading on nonpublic information related to drug-approval applications.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.